Dr Alan Hippe is the latest senior executive featured in The CFO series
IR alumni from Roche – the 130-year-old Swiss pharmaceutical – include Dr Karl Mahler, Thomas Kudsk Larsen and Nina Goworek. Dr Bruno Eschli, the company’s IR lead for more than four years, delivers an impressive mix of capital markets and science – including an immunology post doctorate in the lab of Nobel laureates Rolf Zinkernagel and Hans Hengartner.
Given this impressive list – and the many more high-IR achievers to come out of the Basel-headquartered firm, what does CFO Dr Alan Hippe look for from his head of IR? As Hippe explains in his profile for The CFO series with IR Impact, Mahler and Eschli bring different personalities to the role – while also sharing key attributes that Hippe has come to appreciate over his 15 years with Roche and many more in other prominent CFO seats.
Our back catalogue features more than two years of deep dive discussions with global CFOs as they talk all things IR. You can read about how Reddit’s Drew Vollero measures IR success, how Infineon’s Dr Sven Schneider fared on 30 conferences and 20 roadshows in a single year or hear the advice that Andrea James of Oncocyte got from a former marine that still guides her approach to IR today.
Enjoy access to this and more – for free!
Log in or create your free My IR – Essentials account to:
- Get access to 3 free IR deep dives
- More than 100 pieces of insight, plus our exclusive CFO interviews
- Save favorites and get personalized content on your dashboard
- Enjoy 10% off all IR forums
